IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$773M
AUM Growth
+$278M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1 +$33.1M
2 +$14.6M
3 +$14.3M
4
OLMA icon
Olema Pharmaceuticals
OLMA
+$13.5M
5
LLY icon
Eli Lilly
LLY
+$13.2M

Top Sells

1 +$53M
2 +$20.7M
3 +$16M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$11.8M

Sector Composition

1 Healthcare 99.47%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYRA icon
126
Lyra Therapeutics
LYRA
$2.25M
$65.2K 0.01%
21,161
JSPR icon
127
Jasper Therapeutics
JSPR
$39.2M
$44.1K 0.01%
24,093
-1,014
AEMD icon
128
Aethlon Medical
AEMD
$2.46M
$39.8K 0.01%
14,364
-1,002
RZLT icon
129
Rezolute
RZLT
$303M
$38.9K 0.01%
+16,479
PHGE icon
130
BiomX
PHGE
$9.23M
$36.4K ﹤0.01%
19,473
-1,210
AIRS icon
131
AirSculpt Technologies
AIRS
$122M
$32.5K ﹤0.01%
16,398
-1,553
TOVX icon
132
Theriva Biologics
TOVX
$6.65M
$23.6K ﹤0.01%
112,076
-7,955
SYBX
133
DELISTED
Synlogic
SYBX
$22.4K ﹤0.01%
19,966
-456
ANEB
134
DELISTED
Anebulo Pharmaceuticals
ANEB
$17.9K ﹤0.01%
17,736
-139,984
AMIX
135
Autonomix Medical
AMIX
$4.68M
$10.3K ﹤0.01%
18,688
-1,312
AKRO
136
DELISTED
Akero Therapeutics
AKRO
-206,854
ALT icon
137
Altimmune
ALT
$505M
0
ANAB icon
138
AnaptysBio
ANAB
$1.68B
-48,410
ANIP icon
139
ANI Pharmaceuticals
ANIP
$1.7B
0
AQST icon
140
Aquestive Therapeutics
AQST
$514M
0
ARCT icon
141
Arcturus Therapeutics
ARCT
$209M
-10,721
ARGX icon
142
argenx
ARGX
$45.4B
-5,942
BBIO icon
143
BridgeBio Pharma
BBIO
$12.7B
-51,967
BMY icon
144
Bristol-Myers Squibb
BMY
$125B
0
CNTA
145
Centessa Pharmaceuticals
CNTA
$3.85B
0
COGT icon
146
Cogent Biosciences
COGT
$6.1B
-11,280
CRBP icon
147
Corbus Pharmaceuticals
CRBP
$139M
0
CRNX icon
148
Crinetics Pharmaceuticals
CRNX
$4.02B
-130,902
DNTH icon
149
Dianthus Therapeutics
DNTH
$2.69B
-346,001
DXCM icon
150
DexCom
DXCM
$27.5B
0